Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study to Evaluate the Efficacy and Safety of CS32582 in Participants With Moderate to Severe Plaque PsoriasisPlaque PsoriasisRecruitingPhase 1 / Phase 22025-09-10NCT07129382

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Chipscreen Biosciences, Ltd.15

11 results · Page 1 of 1

Swipe the table sideways for more columns.